IP50-10: A Histopathology-Driven AI Biomarker for Predicting Progression, High-Grade Recurrence, and Early BCG Failure in NMIBC

IP50-10: A Histopathology-Driven AI Biomarker for Predicting Progression, High-Grade Recurrence, and Early BCG Failure in NMIBC

Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Speakers

Kyle Richards

Associate ProfessorUniversity of Wisconsin, Department of Urology, Division of Urologic Oncology

Sessions

IP50: Bladder Cancer: Non-invasive IV

Sunday, May 17, 2026 7:00 AM to 9:00 AM

Christopher Anderson · Columbia University Medical Center

William Tabayoyong · Department of Urology

Mary Westerman · Department of Urology, University of North Carolina

Registered attendees

Keegan Steele

Urology ResidentUniversity of Wisconsin

Log in

See all the content and easy-to-use features by logging in or registering!